Mucosal Adjuvanticity of Immunostimulatory DNA Sequences

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 2000 Aug 17

PMID 10944808

Citations 1

Authors

A A Horner

N Cinman

A Ronaghy

E Raz

Affiliations

Soon will be listed here.

Citing Articles

Impairment by mucosal adjuvants and cross-reactivity with variant peptides of the mucosal immunity induced by injection of the fusion peptide PADRE-ELDKWA.

Decroix N, Pamonsinlapatham P, Quan C, Bouvet J Clin Diagn Lab Immunol. 2003; 10(6):1103-8.

PMID: 14607874 PMC: 262446. DOI: 10.1128/cdli.10.6.1103-1108.2003.

References

Haneberg B, Kendall D, Amerongen H, Apter F, Kraehenbuhl J, Neutra M . Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun. 1994; 62(1):15-23. PMC: 186061. DOI: 10.1128/iai.62.1.15-23.1994. View

Kobayashi H, Van Uden J, Nguyen M, Kornbluth R, Raz E . Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol. 1999; 11(7):1111-8. DOI: 10.1093/intimm/11.7.1111. View

Shahinian A, Pfeffer K, Lee K, Kundig T, Kishihara K, Wakeham A . Differential T cell costimulatory requirements in CD28-deficient mice. Science. 1993; 261(5121):609-12. DOI: 10.1126/science.7688139. View

Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J . Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992; 175(3):671-82. PMC: 2119142. DOI: 10.1084/jem.175.3.671. View

Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T . Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J Immunol. 1992; 148(12):4072-6. View

Mosmann T, Coffman R . TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989; 7:145-73. DOI: 10.1146/annurev.iy.07.040189.001045. View

Assenmacher M, Schmitz J, Radbruch A . Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol. 1994; 24(5):1097-101. DOI: 10.1002/eji.1830240513. View

Carpenter E, Ruby J, Ramshaw I . IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J Immunol. 1994; 152(6):2652-9. View

Pisetsky D . Immune activation by bacterial DNA: a new genetic code. Immunity. 1996; 5(4):303-10. DOI: 10.1016/s1074-7613(00)80256-3. View

10.

Jakob T, Walker P, Krieg A, Udey M, Vogel J . Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol. 1998; 161(6):3042-9. View

11.

Zimmermann S, Egeter O, Hausmann S, Lipford G, Rocken M, Wagner H . CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol. 1998; 160(8):3627-30. View

12.

Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen R, Chatila T . Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993; 90(6):2170-3. PMC: 46047. DOI: 10.1073/pnas.90.6.2170. View

13.

McCluskie M, Davis H . CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol. 1998; 161(9):4463-6. View

14.

Letvin N . Progress in the development of an HIV-1 vaccine. Science. 1998; 280(5371):1875-80. DOI: 10.1126/science.280.5371.1875. View

15.

Webb A, Cunningham D, Cotter F, Clarke P, Di Stefano F, Ross P . BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet. 1997; 349(9059):1137-41. DOI: 10.1016/s0140-6736(96)11103-x. View

16.

Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K . The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med. 1988; 167(2):332-44. PMC: 2188837. DOI: 10.1084/jem.167.2.332. View

17.

Vancott T, Kaminski R, Mascola J, Kalyanaraman V, Wassef N, Alving C . HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol. 1998; 160(4):2000-12. View

18.

Davis H, Weeratna R, Waldschmidt T, Tygrett L, Schorr J, Krieg A . CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 1998; 160(2):870-6. View

19.

Marinaro M, Staats H, Hiroi T, Jackson R, Coste M, Boyaka P . Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol. 1995; 155(10):4621-9. View

20.

Okahashi N, Yamamoto M, Vancott J, Chatfield S, Roberts M, Bluethmann H . Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun. 1996; 64(5):1516-25. PMC: 173956. DOI: 10.1128/iai.64.5.1516-1525.1996. View